Type 1 IFNs may mediate Zika pregnancy complications

Type 1 IFNs may mediate zika pregnancy complications

(HealthDay)—Type 1 interferons (IFNs) may mediate pregnancy complications in the context of congenital Zika virus (ZIKV) infection, according to a study published in the Jan. 5 issue of Science Immunology.

Laura J. Yockey, from the Yale University School of Medicine in New Haven, Conn., and colleagues examined the role of type 1 IFNs in limiting or mediating ZIKV disease within a model of , observed after ZIKV of type I IFN receptor knockout (ifnar1−/−) dams mating with wild-type sires, resulting in fetuses with functional type 1 IFN signaling. Pregnant dams carried a mixture of fetuses that expressed or did not express IFN-α/β receptor (IFNAR) (ifnar1+/− and ifnar1−/−) within the same uterus.

The researchers found that the titer of virus replication was higher in the placenta of ifnar1−/− than ifnar1+/−. Only ifnar1+/− fetuses were resorbed after ZIKV infection during early pregnancy; ifnar1−/− littermates continued to develop. IFNAR signaling in the conceptus was found to inhibit development of the placental labyrinth, resulting in abnormal maternal-fetal barrier architecture after ZIKV infection. Exposure of midgestation human chorionic villous explants to type I IFN resulted in altered placental morphology and cytoskeletal rearrangements within the villous core; this was not seen with exposure to type III IFN.

"Our results implicate type I IFNs as a possible mediator of , including spontaneous abortions and growth restriction, in the context of congenital viral infections," the authors write.


Explore further

How Zika infection drives fetal demise

More information: Abstract
Full Text
Journal information: Science Immunology

Copyright © 2018 HealthDay. All rights reserved.

Citation: Type 1 IFNs may mediate Zika pregnancy complications (2018, January 8) retrieved 22 August 2019 from https://medicalxpress.com/news/2018-01-ifns-zika-pregnancy-complications.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
7 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more